Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC lessened its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 6.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 592,257 shares of the company's stock after selling 37,822 shares during the period. Prestige Consumer Healthcare comprises about 2.4% of Rice Hall James & Associates LLC's portfolio, making the stock its 8th largest holding. Rice Hall James & Associates LLC owned 1.19% of Prestige Consumer Healthcare worth $40,777,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of PBH. Vanguard Group Inc. boosted its holdings in Prestige Consumer Healthcare by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 5,756,138 shares of the company's stock worth $352,391,000 after buying an additional 63,375 shares during the last quarter. Victory Capital Management Inc. boosted its holdings in Prestige Consumer Healthcare by 9.0% in the 2nd quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company's stock worth $142,827,000 after buying an additional 171,357 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in shares of Prestige Consumer Healthcare by 26.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,320,125 shares of the company's stock worth $90,891,000 after purchasing an additional 272,773 shares during the last quarter. Congress Asset Management Co. MA boosted its holdings in shares of Prestige Consumer Healthcare by 12.5% during the 1st quarter. Congress Asset Management Co. MA now owns 764,013 shares of the company's stock worth $55,437,000 after purchasing an additional 84,757 shares during the last quarter. Finally, The Manufacturers Life Insurance Company boosted its holdings in shares of Prestige Consumer Healthcare by 5.3% during the 4th quarter. The Manufacturers Life Insurance Company now owns 605,376 shares of the company's stock worth $37,061,000 after purchasing an additional 30,288 shares during the last quarter. Hedge funds and other institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Trading Down 1.4 %

NYSE PBH traded down $0.99 on Wednesday, reaching $71.12. The stock had a trading volume of 160,706 shares, compared to its average volume of 247,716. Prestige Consumer Healthcare Inc. has a 12-month low of $56.34 and a 12-month high of $75.80. The stock has a fifty day moving average price of $70.46 and a two-hundred day moving average price of $69.49. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $3.52 billion, a price-to-earnings ratio of 17.06, a P/E/G ratio of 2.10 and a beta of 0.48.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, topping analysts' consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The business had revenue of $267.10 million for the quarter, compared to analyst estimates of $260.54 million. During the same quarter in the prior year, the company earned $1.06 earnings per share. The company's revenue was down 4.4% on a year-over-year basis. As a group, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current fiscal year.

Analysts Set New Price Targets

PBH has been the topic of several recent research reports. Canaccord Genuity Group restated a "buy" rating and set a $80.00 target price on shares of Prestige Consumer Healthcare in a report on Tuesday, May 21st. StockNews.com lowered shares of Prestige Consumer Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, May 21st. Finally, DA Davidson lifted their price target on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a "buy" rating in a research report on Wednesday, August 28th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $98.75.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.